Detalles de la búsqueda
1.
Long-term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes.
Catheter Cardiovasc Interv
; 103(2): 276-285, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38091338
2.
Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
Catheter Cardiovasc Interv
; 101(1): 13-21, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36378691
3.
Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial.
Circulation
; 143(22): 2155-2165, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33823606
4.
Impact of diabetes on 1-year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial.
Catheter Cardiovasc Interv
; 99(4): 1095-1103, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043539
5.
Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
Catheter Cardiovasc Interv
; 99(7): 1965-1975, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35384254
6.
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.
Eur Heart J
; 42(44): 4536-4549, 2021 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389857
7.
Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: The SORT OUT IX Trial.
Circulation
; 141(25): 2052-2063, 2020 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32434381
8.
Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004-2016.
BMC Cardiovasc Disord
; 21(1): 579, 2021 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34863111
9.
Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial.
Am Heart J
; 213: 1-7, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31055192
10.
Impact of diabetes on clinical outcomes after revascularization with sirolimus-eluting and biolimus-eluting stents with biodegradable polymer from the SORT OUT VII trial.
Catheter Cardiovasc Interv
; 93(4): 567-573, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30244533
11.
Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT) X trial.
Am Heart J
; 202: 49-53, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29807307
12.
Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.
Lancet
; 387(10034): 2199-206, 2016 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27053444
13.
Coronary artery disease and risk of adverse cardiac events and stroke.
Eur J Clin Invest
; 47(11): 819-828, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28804899
14.
Chronic total coronary occlusion: treatment results.
Scand Cardiovasc J
; 51(4): 197-201, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28425767
15.
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3PRIMULTI): an open-label, randomised controlled trial.
Lancet
; 386(9994): 665-71, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26347918
16.
Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.
Lancet
; 385(9977): 1527-35, 2015 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25601789
17.
Impact of Percutaneous Intervention Compared to Pharmaceutical Therapy on Complex Arrhythmias in Patients With Chronic Total Coronary Occlusion. Rationale and Design of the CTO-ARRHYTHMIA Study.
Cardiovasc Revasc Med
; 54: 69-72, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37117085
18.
Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial.
Circ Cardiovasc Interv
; 16(1): e012332, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36649389
19.
Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SORT OUT X randomised clinical trial.
EuroIntervention
; 19(8): 676-683, 2023 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584207
20.
Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients.
Eur Heart J Acute Cardiovasc Care
; 12(1): 22-37, 2023 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36346109